Medicine shouldn’t just be cheap; it should be accessible
KRYSTLE WITTEVRONGEL: New drug price guidelines will hinder Canadians access to new and innovative treatments
Select Page
by Krystle Wittevrongel | Feb 2, 2023
KRYSTLE WITTEVRONGEL: New drug price guidelines will hinder Canadians access to new and innovative treatments
by Nigel Rawson | May 7, 2022
by Maria Lily Shaw | Jun 28, 2021
by Bacchus Barua | Oct 30, 2020
by Peter Holle | Oct 25, 2019
SUSAN MARTINUK: Free prescription drugs won’t mean a thing if Canadians can’t access the drugs they need. There has to be a better way to manage our supply (FREE membership content)
by Michael Taube | Oct 1, 2019
MICHAEL TAUBE: Canadians have witnessed major scandals, offensive remarks, daily mud-slinging and policy proposals with big, shiny numbers that are wasteful enough to make adults cry (PREMIUM content/Not yet a PREMIUM member? $21)
by The Fraser Institute | Sep 24, 2019
KATRINA ACRI: Canada must cautiously approach any policy change that puts patients, innovation and innovative industries at risk
by Bacchus Barua | Sep 8, 2019
BACCHUS BARUA and KRISTINA ACRI: Both countries partner with the private sector and expect patients to share the cost of treatment
by Yanick Labrie | Sep 6, 2019
YANICK LABRIE: Public coverage in Quebec is not only more generous, but drug approval is more timely than anywhere else in the country
by Kristina Acri | Mar 14, 2019
Will likely result in reduced access to new drugs, and delay research and development
Click here to JOIN us